{"entity":{"type":"insider","cik":"0001808505","url":"/insider/0001808505","json_url":"/insider/0001808505.json","name":"Rickard Jason","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":28,"n_filings":14,"first":"2020-05-13","last":"2023-03-01","span_basis":"filed_date"},"name_variants":[{"name":"Rickard Jason","source":"filing","n_filings":14,"first_seen":"2020-05-13","last_seen":"2023-03-01"}],"transactions":[{"id":8249056,"accession":"0001209191-23-014285","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-014285","line_url":"/filing/0001209191-23-014285","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808505","owner_name":"Rickard Jason","owner_display_name":"Rickard Jason","owner_url":"/insider/0001808505","role":"Officer (SVP, Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Operating Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17429.0,"shares_display":"17,429","price_per_share":11.31,"price_display":"11.31","price_state":"stated","total_value":197121.99,"total_display":"197,121.99","total_whole":"197,122","shares_owned_after":336090.0,"shares_owned_after_display":"336,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-28","filed_date":"2023-03-01","scope":"insider","n_lines":2},{"id":8249050,"accession":"0001209191-23-014285","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-014285","line_url":"/filing/0001209191-23-014285","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808505","owner_name":"Rickard Jason","owner_display_name":"Rickard Jason","owner_url":"/insider/0001808505","role":"Officer (SVP, Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Operating Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16746.0,"shares_display":"16,746","price_per_share":11.41,"price_display":"11.41","price_state":"stated","total_value":191071.86,"total_display":"191,071.86","total_whole":"191,072","shares_owned_after":353385.0,"shares_owned_after_display":"353,385","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-27","filed_date":"2023-03-01","scope":"insider","n_lines":2},{"id":6498051,"accession":"0001209191-22-061644","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-061644","line_url":"/filing/0001209191-22-061644#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808505","owner_name":"Rickard Jason","owner_display_name":"Rickard Jason","owner_url":"/insider/0001808505","role":"Officer (SVP, Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Operating Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27000.0,"shares_display":"27,000","price_per_share":12.39,"price_display":"12.39","price_state":"stated","total_value":334530.0,"total_display":"334,530.00","total_whole":"334,530","shares_owned_after":348736.0,"shares_owned_after_display":"348,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-14","filed_date":"2022-12-16","scope":"insider"},{"id":6925951,"accession":"0001209191-22-046223","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-046223","line_url":"/filing/0001209191-22-046223#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808505","owner_name":"Rickard Jason","owner_display_name":"Rickard Jason","owner_url":"/insider/0001808505","role":"Officer (SVP, Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Operating Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":994.0,"shares_display":"994","price_per_share":11.77,"price_display":"11.77","price_state":"stated","total_value":11699.38,"total_display":"11,699.38","total_whole":"11,699","shares_owned_after":375736.0,"shares_owned_after_display":"375,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-15","filed_date":"2022-08-17","scope":"insider"},{"id":6893142,"accession":"0001209191-22-045179","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-045179","line_url":"/filing/0001209191-22-045179#line-4","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808505","owner_name":"Rickard Jason","owner_display_name":"Rickard Jason","owner_url":"/insider/0001808505","role":"Officer (SVP, Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Operating Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18041.0,"shares_display":"18,041","price_per_share":11.75,"price_display":"11.75","price_state":"stated","total_value":211981.75,"total_display":"211,981.75","total_whole":"211,982","shares_owned_after":376730.0,"shares_owned_after_display":"376,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-09","filed_date":"2022-08-10","scope":"insider"},{"id":6893134,"accession":"0001209191-22-045179","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-045179","line_url":"/filing/0001209191-22-045179","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808505","owner_name":"Rickard Jason","owner_display_name":"Rickard Jason","owner_url":"/insider/0001808505","role":"Officer (SVP, Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Operating Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29436.0,"shares_display":"29,436","price_per_share":11.633923087376003,"price_display":"11.63","price_state":"stated","total_value":342456.16,"total_display":"342,456.16","total_whole":"342,456","shares_owned_after":378966.0,"shares_owned_after_display":"378,966","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-08","filed_date":"2022-08-10","scope":"insider","n_lines":2},{"id":6728293,"accession":"0001209191-22-031841","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-031841","line_url":"/filing/0001209191-22-031841","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808505","owner_name":"Rickard Jason","owner_display_name":"Rickard Jason","owner_url":"/insider/0001808505","role":"Officer (SVP, Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Operating Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13537.0,"shares_display":"13,537","price_per_share":11.5,"price_display":"11.50","price_state":"stated","total_value":155675.5,"total_display":"155,675.50","total_whole":"155,676","shares_owned_after":404074.0,"shares_owned_after_display":"404,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-23","filed_date":"2022-05-25","scope":"insider","n_lines":2},{"id":6481589,"accession":"0001209191-22-014650","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-22-014650","line_url":"/filing/0001209191-22-014650","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808505","owner_name":"Rickard Jason","owner_display_name":"Rickard Jason","owner_url":"/insider/0001808505","role":"Officer (SVP, Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Operating Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28962.0,"shares_display":"28,962","price_per_share":10.77,"price_display":"10.77","price_state":"stated","total_value":311920.74,"total_display":"311,920.74","total_whole":"311,921","shares_owned_after":333933.0,"shares_owned_after_display":"333,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-28","filed_date":"2022-03-02","scope":"insider","n_lines":5},{"id":5407209,"accession":"0001209191-21-070549","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-070549","line_url":"/filing/0001209191-21-070549#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808505","owner_name":"Rickard Jason","owner_display_name":"Rickard Jason","owner_url":"/insider/0001808505","role":"Officer (SVP, Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Operating Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27000.0,"shares_display":"27,000","price_per_share":11.28,"price_display":"11.28","price_state":"stated","total_value":304560.0,"total_display":"304,560.00","total_whole":"304,560","shares_owned_after":319901.0,"shares_owned_after_display":"319,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-16","filed_date":"2021-12-20","scope":"insider"},{"id":4588700,"accession":"0001209191-21-066782","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-066782","line_url":"/filing/0001209191-21-066782","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808505","owner_name":"Rickard Jason","owner_display_name":"Rickard Jason","owner_url":"/insider/0001808505","role":"Officer (SVP, Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Operating Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17193.0,"shares_display":"17,193","price_per_share":11.58,"price_display":"11.58","price_state":"stated","total_value":199094.94,"total_display":"199,094.94","total_whole":"199,095","shares_owned_after":344665.0,"shares_owned_after_display":"344,665","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-23","filed_date":"2021-11-24","scope":"insider","n_lines":2},{"id":5400028,"accession":"0001209191-21-052199","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-052199","line_url":"/filing/0001209191-21-052199#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808505","owner_name":"Rickard Jason","owner_display_name":"Rickard Jason","owner_url":"/insider/0001808505","role":"Officer (SVP, Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Operating Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":680.0,"shares_display":"680","price_per_share":13.48,"price_display":"13.48","price_state":"stated","total_value":9166.4,"total_display":"9,166.40","total_whole":"9,166","shares_owned_after":361858.0,"shares_owned_after_display":"361,858","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-16","filed_date":"2021-08-18","scope":"insider"},{"id":4180640,"accession":"0001209191-21-035900","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-035900","line_url":"/filing/0001209191-21-035900#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808505","owner_name":"Rickard Jason","owner_display_name":"Rickard Jason","owner_url":"/insider/0001808505","role":"Officer (SVP, Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Operating Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":516.0,"shares_display":"516","price_per_share":12.25,"price_display":"12.25","price_state":"stated","total_value":6321.0,"total_display":"6,321.00","total_whole":"6,321","shares_owned_after":362538.0,"shares_owned_after_display":"362,538","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-24","filed_date":"2021-05-26","scope":"insider"},{"id":4660171,"accession":"0001209191-21-016099","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-016099","line_url":"/filing/0001209191-21-016099","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808505","owner_name":"Rickard Jason","owner_display_name":"Rickard Jason","owner_url":"/insider/0001808505","role":"Officer (SVP, Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Operating Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13651.0,"shares_display":"13,651","price_per_share":9.11,"price_display":"9.11","price_state":"stated","total_value":124360.61,"total_display":"124,360.61","total_whole":"124,361","shares_owned_after":306682.0,"shares_owned_after_display":"306,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-26","filed_date":"2021-03-02","scope":"insider","n_lines":4},{"id":2883672,"accession":"0001209191-20-057617","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-057617","line_url":"/filing/0001209191-20-057617#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808505","owner_name":"Rickard Jason","owner_display_name":"Rickard Jason","owner_url":"/insider/0001808505","role":"Officer (SVP, Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Operating Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":394.0,"shares_display":"394","price_per_share":10.92,"price_display":"10.92","price_state":"stated","total_value":4302.48,"total_display":"4,302.48","total_whole":"4,302","shares_owned_after":235382.0,"shares_owned_after_display":"235,382","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-09","filed_date":"2020-11-10","scope":"insider"},{"id":2587388,"accession":"0001209191-20-047472","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-047472","line_url":"/filing/0001209191-20-047472#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808505","owner_name":"Rickard Jason","owner_display_name":"Rickard Jason","owner_url":"/insider/0001808505","role":"Officer (SVP, Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Operating Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":689.0,"shares_display":"689","price_per_share":10.14,"price_display":"10.14","price_state":"stated","total_value":6986.46,"total_display":"6,986.46","total_whole":"6,986","shares_owned_after":235776.0,"shares_owned_after_display":"235,776","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-19","scope":"insider"},{"id":3113725,"accession":"0001209191-20-028906","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-028906","line_url":"/filing/0001209191-20-028906#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808505","owner_name":"Rickard Jason","owner_display_name":"Rickard Jason","owner_url":"/insider/0001808505","role":"Officer (SVP, Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Operating Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":510.0,"shares_display":"510","price_per_share":10.35,"price_display":"10.35","price_state":"stated","total_value":5278.5,"total_display":"5,278.50","total_whole":"5,279","shares_owned_after":234580.0,"shares_owned_after_display":"234,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-11","filed_date":"2020-05-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":28,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":28,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":28},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001446847","name":"IRONWOOD PHARMACEUTICALS INC","url":"/issuer/0001446847","role":"Officer (SVP, Chief Operating Officer)","n_filings":14,"first_seen":"2020-05-13","last_seen":"2023-03-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001808505","retrieved_at":"2026-08-22T20:41:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}